Trial description
 A phase III randomised trial investigating the combination of dose-fractionated chemotherapy & bevacizumab compared to either strategy alone for the first line treatment of women with newly diagnosed high risk stage III-IV epithelial ovarian, fallopian tube or primary peritoneal cancer
Contact name
Dr Christine Parkinson
Trial start date
Wednesday, February 8, 2012
Trial end date
Tuesday, December 31, 2019
Trial tumour type
Show on Radiotherapy